Second Meeting of the French CEIP (Centres d'Évaluation et d'Information sur la Pharmacodépendance). Part I: How to Evaluate and Prevent the Abuse and Dependence on Hypnotic/Anxiolytic Drugs?
- Author
- MICALLEF-ROLL, Joëlle1 ; LAPEYRE-MESTRE, Maryse2
[1] Centre d'Évaluation et d'Information sur la Pharmacodépendance CEIP Addictovigilance, PACA-Corse, Centre Associé, Service de Pharmacologie Clinique, Marseille, France
[2] Centre d'Évaluation et d'Information sur la Pharmacodépendance Addictovigilance CEIP Midi-Pyrénées, Toulouse, France
Association Française des Centres d'Evaluation et d'Information sur la Pharmacodependance-Addictovigilance, France - Source
Thérapie (Paris). 2009, Vol 64, Num 6, pp 355-364, 10 p ; ref : 43 ref
- CODEN
- THERAP
- ISSN
- 0040-5957
- Scientific domain
- Pharmacology drugs
- Publisher
- EDP Sciences, Les Ulis
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- abus addiction anxiolytiques hypnotiques pharmacodépendance pharmacoépidémiologie
- Keyword (fr)
- Abus Addiction Congrès Dépendance Epidémiologie Evaluation Homme Hypnotique Information Médicament Personne âgée Prévention Psychotrope Tranquillisant Abus médicamenteux France Europe
- Keyword (en)
- Abuse Addiction Congress Dependence Epidemiology Evaluation Human Hypnotic Information Drug Elderly Prevention Psychotropic Tranquillizer Medication overuse France Europe
- Keyword (es)
- Abuso Adicción Congreso Dependencia Epidemiología Evaluación Hombre Hipnótico Información Medicamento Anciano Prevención Psicotropo Tranquilizante Francia Europa
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02A General pharmacology / 002B02A06 Clinical trial. Drug monitoring
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B03 Psycholeptics: tranquillizer, neuroleptic.
- Francis
- 770 Psychology. Psychoanalysis. Psychiatry / 770-E Psychopharmacology / 770-E03 Psycholeptics: tranquillizer, neuroleptic…
- Discipline
- General pharmacology Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology
- Origin
- Inist-CNRS
- Database
- FRANCIS ; PASCAL
- INIST identifier
- 22289482
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.2515/therapie/2009054 
https://dx.doi.org/10.2515/therapie/2009054
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.2515\/therapie\/2009054\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:193:\"Second Meeting of the French CEIP (Centres d'\u00c9valuation et d'Information sur la Pharmacod\u00e9pendance). Part I: How to Evaluate and Prevent the Abuse and Dependence on Hypnotic\/Anxiolytic Drugs?\";s:9:\"\u0000*\u0000jtitle\";s:17:\"Th\u00e9rapie (Paris)\";s:9:\"\u0000*\u0000stitle\";s:17:\"Th\u00e9rapie (Paris)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"64\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"355\";s:8:\"\u0000*\u0000epage\";s:3:\"364\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0040-5957\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:13:\"MICALLEF-ROLL\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Jo\u00eblle\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:22:\"LAPEYRE-MESTRE, Maryse\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"THERAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:193:\"Second Meeting of the French CEIP (Centres d'\u00c9valuation et d'Information sur la Pharmacod\u00e9pendance). Part I: How to Evaluate and Prevent the Abuse and Dependence on Hypnotic\/Anxiolytic Drugs?\";s:8:\"\u0000*\u0000place\";s:8:\"Les Ulis\";s:6:\"\u0000*\u0000pub\";s:12:\"EDP Sciences\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.2515\/therapie\/2009054\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:193:\"Second Meeting of the French CEIP (Centres d'\u00c9valuation et d'Information sur la Pharmacod\u00e9pendance). Part I: How to Evaluate and Prevent the Abuse and Dependence on Hypnotic\/Anxiolytic Drugs?\";s:9:\"\u0000*\u0000jtitle\";s:17:\"Th\u00e9rapie (Paris)\";s:9:\"\u0000*\u0000stitle\";s:17:\"Th\u00e9rapie (Paris)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"64\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"355\";s:8:\"\u0000*\u0000epage\";s:3:\"364\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0040-5957\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:13:\"MICALLEF-ROLL\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Jo\u00eblle\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:22:\"LAPEYRE-MESTRE, Maryse\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"THERAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:193:\"Second Meeting of the French CEIP (Centres d'\u00c9valuation et d'Information sur la Pharmacod\u00e9pendance). Part I: How to Evaluate and Prevent the Abuse and Dependence on Hypnotic\/Anxiolytic Drugs?\";s:8:\"\u0000*\u0000place\";s:8:\"Les Ulis\";s:6:\"\u0000*\u0000pub\";s:12:\"EDP Sciences\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:24:\"10.2515\/therapie\/2009054\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.2515\/therapie\/2009054\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:193:\"Second Meeting of the French CEIP (Centres d'\u00c9valuation et d'Information sur la Pharmacod\u00e9pendance). Part I: How to Evaluate and Prevent the Abuse and Dependence on Hypnotic\/Anxiolytic Drugs?\";s:9:\"\u0000*\u0000jtitle\";s:17:\"Th\u00e9rapie (Paris)\";s:9:\"\u0000*\u0000stitle\";s:17:\"Th\u00e9rapie (Paris)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"64\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"355\";s:8:\"\u0000*\u0000epage\";s:3:\"364\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0040-5957\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:13:\"MICALLEF-ROLL\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Jo\u00eblle\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:22:\"LAPEYRE-MESTRE, Maryse\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"THERAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:193:\"Second Meeting of the French CEIP (Centres d'\u00c9valuation et d'Information sur la Pharmacod\u00e9pendance). Part I: How to Evaluate and Prevent the Abuse and Dependence on Hypnotic\/Anxiolytic Drugs?\";s:8:\"\u0000*\u0000place\";s:8:\"Les Ulis\";s:6:\"\u0000*\u0000pub\";s:12:\"EDP Sciences\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.2515\/therapie\/2009054\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:193:\"Second Meeting of the French CEIP (Centres d'\u00c9valuation et d'Information sur la Pharmacod\u00e9pendance). Part I: How to Evaluate and Prevent the Abuse and Dependence on Hypnotic\/Anxiolytic Drugs?\";s:9:\"\u0000*\u0000jtitle\";s:17:\"Th\u00e9rapie (Paris)\";s:9:\"\u0000*\u0000stitle\";s:17:\"Th\u00e9rapie (Paris)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"64\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"355\";s:8:\"\u0000*\u0000epage\";s:3:\"364\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0040-5957\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:13:\"MICALLEF-ROLL\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Jo\u00eblle\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:22:\"LAPEYRE-MESTRE, Maryse\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"THERAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:193:\"Second Meeting of the French CEIP (Centres d'\u00c9valuation et d'Information sur la Pharmacod\u00e9pendance). Part I: How to Evaluate and Prevent the Abuse and Dependence on Hypnotic\/Anxiolytic Drugs?\";s:8:\"\u0000*\u0000place\";s:8:\"Les Ulis\";s:6:\"\u0000*\u0000pub\";s:12:\"EDP Sciences\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.2515\/therapie\/2009054\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:193:\"Second Meeting of the French CEIP (Centres d'\u00c9valuation et d'Information sur la Pharmacod\u00e9pendance). Part I: How to Evaluate and Prevent the Abuse and Dependence on Hypnotic\/Anxiolytic Drugs?\";s:9:\"\u0000*\u0000jtitle\";s:17:\"Th\u00e9rapie (Paris)\";s:9:\"\u0000*\u0000stitle\";s:17:\"Th\u00e9rapie (Paris)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"64\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"355\";s:8:\"\u0000*\u0000epage\";s:3:\"364\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0040-5957\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:13:\"MICALLEF-ROLL\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Jo\u00eblle\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:22:\"LAPEYRE-MESTRE, Maryse\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"THERAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:193:\"Second Meeting of the French CEIP (Centres d'\u00c9valuation et d'Information sur la Pharmacod\u00e9pendance). Part I: How to Evaluate and Prevent the Abuse and Dependence on Hypnotic\/Anxiolytic Drugs?\";s:8:\"\u0000*\u0000place\";s:8:\"Les Ulis\";s:6:\"\u0000*\u0000pub\";s:12:\"EDP Sciences\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
